Ras

ARS-1323-alkyne is a switch-II pocket (S-IIP) inhibitor and a conformational specific chemical reporter of KRASG12C …

PROTAC K-Ras Degrader-1 is potent degrader of K-Ras based PROTAC.

ARS-1620 is a covalent inhibitor of K-RASG12C.

3344 is an inhibitor of KRAS-effector interactions,with an affnity of 126nm.

KRAS inhibitor-8 is a potent KRAS G12C inhibitor.

KRas G12C inhibitor 1 is a compound that inhibits KRas G12C.

KRAS G12C inhibitor 15 is a potent KRAS G12C inhibitor .

KRAS G12C inhibitor 17 is a potent KRAS G12C inhibitor.

KRAS G12C inhibitor 14 is a potent KRAS G12C inhibitor .

KRAS inhibitor-9 is a potent KRAS inhibitor with Kd of 92 μM that blocks the …

BI-3406 is an orally active, highly potent and selective between KRAS and Son of Sevenless …

Antineoplaston A10 is a naturally occurring substance and the first antineoplaston in the human body …

K-Ras-IN-1 is a K-Ras inhibitor.

KRAS G12C inhibitor 16 is a potent KRAS G12C inhibitor.

KRas G12C inhibitor 3 is a compound that inhibits KRas G12C.

Salirasib(Ki=2.6 μM), an effective competitive prenylated protein methyltransferase (PPMTase) inhibitor, inhibits Ras methylation with potential …

KRAS inhibitor-6 is a potent KRAS G12C inhibitor.

AMG-510 is a selective and orally bioavailable KRAS G12C covalent inhibitor.

MRTX-1257 is a selective, irreversible, and covalent inhibitor of KRAS G12C. It has an IC50 …

KRas G12C inhibitor 2 is a compound that inhibits KRas G12C.

KRAS G12C inhibitor 13 is a KRAS G12C inhibitor .

The compound inhibits Ras function and therefore inhibits the abnormal growth of cells.

Antineoplaston A 10 is a Ras inhibitor potentially for the treatment of glioma, lymphoma, astrocytoma …

MC 976 is a derivative of Vitamin D3.

CID-1067700 is one of the first identified competitive inhibitors of nucleotide binding by Ras-related GTPases(Rab7 …

BI-2852 is a KRAS inhibitor for the switch I/II pocket (SI/II-pocket) with nanomolar affinity. BI-2852 …

KRAS inhibitor-7 is a potent KRAS G12C inhibitor.

ARS-1323 (the racemate of ARS-1620) is a mutant K-ras G12C inhibitor extracted from patent WO …

KRas G12C inhibitor 4 is a compound that inhibits KRas G12C.

1588-A4 is an intermediate of ARS-1620 which is an atropisomeric selective KRASG12C inhibitor with desirable …

Sotorasib is a potent KRAS G12C covalent inhibitor, treatment with AMG 510 led to the …

KB-5246, displays antibacterial activities.is a tetracyclic quinolone.

KRAS G12C inhibitor 5 is a KRas G12C inhibitor.

ARS-1630 is a mutant K-ras G12C inhibitor extracted from patent WO 2015054572 A1. It is …

SCH-54292 is a GDP exchange inhibitor.

MRTX1133 is a potent, selective, noncovalent KRASG12D inhibitor. It has picomolar binding affinity, single-digit nanomolar …

K-Ras G12C-IN-4 is a potent co-valent Inhibitor of KRAS G12C..

Compound 3344 hydrochloride is an inhibitor of KRAS-effector interactions,with an affnity of 126nm.

ML-098 is an activator of the GTP-binding protein Rab7 (EC50: 77.6 nM).

MRTX849 is a potent, selective and covalent KRASG12C inhibitor with potential antineoplastic activity. It selectively …

AMG-510 racemate is a racemic of AMG-510 which is a potent inhibitor of KRAS G12C …

Oncrasin 1 is a potent inhibitor of anticancer that kills various human lung cancer cells …

6H05 TFA is a selective, and allosteric oncogenic mutant K-Ras(G12C) inhibitor.

ML-099 is a pan Ras-related GTPases activator that activates Rac1, Ras, GTP-binding protein (Rab7), Rab2A …

RBC10 inhibits the binding of Ral to its effector RALBP1, as well as inhibiting Ral-mediated …